Ventricular muscarinic receptor remodeling in patients with and without primary ventricular fibrillation. An imaging study

Journal of Nuclear Cardiology

Volumn 19, Issue 5, 2012, Pages 1017-1025

  Mazzadi, Alejandro N ^a,e   Pineau, Julien ^b,c   Costes, Nicolas ^a   Bars, Didier Le ^a,c   Bonnefoi, Fréderic ^a   Porcher, Raphaël ^d   Croisille, Pierre ^b,c   Chevalier, Philippe ^c,e,f  

^a CERMEP IMAGERIE DU VIVANT   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e UNIVERSIDAD NACIONAL DE SAN MARTÍN   (Argentina)

^f LOUIS PRADEL HOSPITAL   (France)

Author keywords

Magnetic resonance imaging; Muscarinic receptors; Myocardial infarction; Positron emission tomography; Ventricular fibrillation

Indexed keywords

CARBON METHYLQUINUCLIDINYL BENZILATE C 11; ISOTOPE; MUSCARINIC RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIAC IMAGING; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE REMODELING; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN DETERMINATION; UPREGULATION;

ADULT; AGED; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, MUSCARINIC; VENTRICULAR FIBRILLATION; VENTRICULAR REMODELING;

EID: 84868198054     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-012-9576-z     Document Type: Article

References (30)

1. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2001;22:1374-450.
2. Fiol M, Marrugat J, Bayes A, Bergada J, Guindo J. Ventricular fibrillation markers on admission to the hospital for acute myocardial infarction. Am J Cardiol 1993;71:117-9.
3. Zipes DP, Rubart M. Neural modulation of cardiac arrhythmias and sudden cardiac death. Heart Rhythm 2006;3:108-13.
4. Sasano T, Abraham MR, Chang KC, Ashikaga H, Mills KJ, Holt DP, et al. Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 2008;51:2266-75.
5. Billman GE. Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: Effect of endurance exercise training. Am J Physiol Heart Circ Physiol 2009;297:H1171-93.
6. Zheng C, Li M, Inagaki M, Kawada T, Sunagawa K, Sugimachi M. Vagal stimulation markedly suppresses arrhythmias in conscious rats with chronic heart failure after myocardial infarction. Conf Proc IEEE Eng Med Biol Soc 2005;7:7072-5.
7. Inagaki M, Kawada T, Lie M, Zheng C, Sunagawa K, Sugimachi M. Intravascular parasympathetic cardiac nerve stimulation prevents ventricular arrhythmias during acute myocardial ischemia. Conf Proc IEEE Eng Med Biol Soc 2005;7:7076-9.
8. Smith LL, Kukielka M, Billman GE. Heart rate recovery after exercise: A predictor of ventricular fibrillation susceptibility after myocardial infarction. Am J Physiol Heart Circ Physiol 2005;288: H1763-9.
9. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998;351:478-84.
10. Chevalier P, Burri H, Adeleine P, Kirkorian G, Lopez M, Leizorovicz A, et al. QT dynamicity and sudden death after myocardial infarction: Results of a long-term follow-up study. J Cardiovasc Electrophysiol 2003;14:227-33.
11. Frenneaux MP. Autonomic changes in patients with heart failure and in post-myocardial infarction patients. Heart 2004;90:1248-55.
12. Bjorkander I, Forslund L, Ericson M, Rehnqvist N, Hjemdahl P, Kahan T. Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction. Clin Physiol Funct Imaging 2009;29:201-8.
13. Mazzadi AN, Pineau J, Costes N, Le Bars D, Bonnefoi F, Croisille P, et al. Muscarinic receptor upregulation in patients with myocardial infarction: A new paradigm. Circ Cardiovasc Imaging 2009;2:365-72.
14. Caldwell JH, Link JM. Imaging left ventricular muscarinic receptor heterogeneity: A tool to evaluate individuals at risk for sudden death? Circ Cardiovasc Imaging 2009;2:353-5.
15. Delforge J, Le Guludec D, Syrota A, Bendriem B, Crouzel C, Slama M, et al. Quantification of myocardial muscarinic receptors with PET in humans. J Nucl Med 1993;34:981-91.
16. Maziere M, Comar D, Godot JM, Collard P, Cepeda C, Naquet R. In vivo characterization of myocardium muscarinic receptors by positron emission tomography. Life Sci 1981;29:2391-7.
17. Frouin V, Comtat C, Reilhac A, Gregoire MC. Correction of partial-volume effect for PET striatal imaging: Fast implementation and study of robustness. J Nucl Med 2002;43:1715-26.
18. Delforge J, Janier M, Syrota A, Crouzel C, Vallois JM, Cayla J, et al. Noninvasive quantification of muscarinic receptors in vivo with positron emission tomography in the dog heart. Circulation 1990;82:1494-504.
19. Ibrahim T, Nekolla SG, Hornke M, Bulow HP, Dirschinger J, Schomig A, et al. Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: Comparison with single-photon emission tomography using Tc99m-sestamibi. J Am Coll Cardiol 2005;45: 544-52.
20. Mazzadi AN, Janier MF, Brossier B, Andre-Fouet X, McFadden E, Revel D, et al. Dobutamine-tagged MRI for inotropic reserve assessment in severe CAD: Relationship with PET findings. Am J Physiol Heart Circ Physiol 2004;286:H1946-53.
21. Vatner DE, Sato N, Galper JB, Vatner SF. Physiological and biochemical evidence for coordinate increases in muscarinic receptors and Gi during pacing-induced heart failure. Circulation 1996;94:102-7.
22. Wilkinson M, Giles A, Armour JA, Cardinal R. Ventricular, but not atrial, M2-muscarinic receptors increase in the canine pacingoverdrive model of heart failure. Can J Cardiol 1996;12:71-6.
23. Chen LN, Zang WJ, Yu XJ, Liu J, Li DL, Kong SS, et al. Compensatory recovery of vagal control of hemodynamics after unilateral vagotomy. Physiol Res 2008;57:119-32.
24. Uno Y, Matsumura K, Scheffel U, Wilson AA, Dannals RF, Wagner HN, et al. Effects of atropine treatment on in vitro and in vivo binding of 4-[125I]-dexetimide to central and myocardial muscarinic receptors. Eur J Nucl Med 1991;18:447-52.
25. Delahaye N, Le Guludec D, Dinanian S, Delforge J, Slama MS, Sarda L, et al. Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy. Circulation 2001;104:2911-6.
26. Mazzadi AN, Andre-Fouet X, Duisit J, Gebuhrer V, Costes N, Chevalier P, et al. Cardiac retention of [11C]HED in genotyped long QT patients: A potential amplifier role for severity of the disease. Am J Physiol Heart Circ Physiol 2003;285:H1286-93.
27. Caldwell JH, Link JM, Levy WC, Poole JE, Stratton Jr. Evidence for pre-to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med 2008;49:234-41.
28. Traish AM, Kim N, Carson MP, de Tejada IS. Characterization of muscarinic acetylcholine receptors in cultured bovine aortic endothelial cells. J Recept Res 1994;14:153-66.
29. Marquetant R, Brehm B, Strasser RH. Chronic beta-blockade transregulates inhibitory A1 adenosine and muscarinic M2 receptors of the adenylyl cyclase system. J Mol Cell Cardiol 1992;24:535-48.
30. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.